Thymidine dinucleotides inhibit contact hypersensitivity and activate the gene for tumor necrosis factor α

Journal of Investigative Dermatology

Volumn 114, Issue 2, 2000, Pages 253-258

  Cruz Jr , Ponciano D ^a   Leverkus, Martin ^b   Dougherty, Irene ^a   Gleason, Michelle J ^b   Eller, Mark ^b   Yaar, Mina ^b   Gilchrest, Barbara A ^b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Delayed type hypersensitivity; Human; Immunomodulators; Rodent

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; PYRIMIDINE NUCLEOTIDE; THYMIDINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTACT ALLERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DNA REPAIR; GENE ACTIVATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TRANSGENIC MOUSE; ULTRAVIOLET B RADIATION;

EID: 1642586715     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2000.00866.x     Document Type: Article

References (58)

1. Applegate LA, Ley RD, Alcalay J, Kripke ML: Identification of the molecular target for the suppression of contact hypersensitivity by ultraviolet radiation. J Exp Med 170:1117-1131, 1989
2. Beutler B, Greenwald D, Hulmes JD, et al: Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature 316:552-554, 1985
3. Black RA, Rauch CT, Kozlosky CJ, et al: A metalloproteinase disintegrin that releases tumour-necrosis factor-Alpha from cells, Nature 385:724-733, 1997
4. Bolognia IL, Pawelek JM: Biology of hypopigmemation. J Am Acad Dermatol 19:217- 255, 1988
5. Bolognia J, Murray M, Pawelek J: UVB-induced melanogenesis may be mediated through the MSH-receptor system. J Invest Dermatol 92:651-656, 1989
6. Brash DE: UV mutagenic photoproducts in Escherichia coli and human cells: a molecular genetics perspective on human skin cancer. Photochem Photobiol 48:59-66, 1988
7. Brash HE, Haseltine WA: UV-induced mutation hotspots occur at DNA damage hotspots. Nature 298:189-192, 1982
8. 2 occurs in mammalian cell membrane preparations. Photochem Photobiol 57:383-390, 1993
9. Cooke A, Johnson BE: Dose response, wavelength dependence and rate of excision of ultraviolet radiation-induced pyrimidine dimers in mouse skin DNA. Biochim Biophys Acta 517:24-30, 1978
10. de Kossodo S, Cruz PD, Jr, Dougherty I, Thompson P, Silva-Valdez M, Beutler B: Expression of the tumor necrosis factor gene by dermal fibroblasts in response to ultraviolet irradiation or lipopolysaccharide. J Invest Dermatol 104:318-322, 1995
11. Devary Y, Rosette C, DiDonato JA, Karin M: NF-kappaB activation by ultraviolet light not dependent on a nuclear signal. Science 261:1442-1445, 1993
12. Donate NJ, Perez M: Tumor necrosis factor-induced apoptosis stimulates p53 accumulation and p21 WAF1 proteolysis in ME-180 cells. J Biol Chem 273:5067-5072, 1998
13. Eller MS, Yaar M, Gilchrest BA: DNA damage and melanogenesis. Nature 372:413-414, 1994
14. Eller MS, Ostrom K, Gilchrest BA: DNA damage enhances melanogenesis. Proc Natl Acad Sci 93:1087-1092, 1996
15. Eller MS, Maeda T, Magnoni C, Atwal D, Gilchrest BA: Enhancement of DNA repair in human skin cells by thymidine dinucleotides: Evidence for a p53-mediated mammalian SOS response. Proc Natl Acad Sci 94:12627-12632, 1997
16. Freeman SE, Hacham H, Gange RW, Maytum DJ, Sutherland JC, Sutherland BM: Wavelength dependence of pyrimidine dimer formation in DNA of human skin irradiated in situ with ultraviolet light. Proc Natl Acad Sci 86:5605-5609, 1989
17. Friedmann PS, Gilchrest BA: Ultraviolet radiation directly induces pigment production by cultured human melanocytes. J Cell Physiol 133:88-94, 1987
18. Gilchrest BA, Eller MS: DNA photodamage stimulates melanogenesis and other photoprotective responses. J Invest Dermatol Sym Proc 4:35-40, 1999
19. Gilchrest BA, Eller MS, Geller AC, Yaar M: The pathogenesis of melanoma induced by ultraviolet light. N Eng J Med 340:1341-1348, 1999
20. Giroir B, Johnson JH, Brown T, Allen GL, Beutler B: The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J Clin Invest 90:693-698, 1992
21. Goukassian DA, Eller MS, Yaar M, Gilchrest BA: Thymidine dinucleotide mimics the effect of solar simulated irradiation on p53 and p53-regulated proteins. J Invest Dermatol 112:25-31, 1999
22. Hart RW, Setlow PB, Woodhead AD: Evidence that pyrimidine dimers in DNA can give rise to tumors. Proc Natl Acad Sci 74:5574-5578, 1977
23. Hayes MP, Freeman SL, Donnelly RP: IFN-gamma priming of monocytes enhances LPS-induced TNF production by augmenting both transcription and mRNA stability. Cytokine 7:427-435, 1995
24. Healy E, Reynolds NJ, Smith MD, Campbell C, Farr PM, Rees JL: Dissociation of erythema and p53 protein expression in human skin following UVB irradiation, and induction of p53 protein and mRNA following application of skin irritants. J Invest Dermatol 103:493-499, 1994
25. Jessup JM, Hanna N, Palaszynski E, Kripke ML: Mechanisms of depressed reactivity to dinitrochlorobenzene and ultraviolet-induced tumors during ultraviolet carcinogenesis in BALBC/c mice. Cell Immunol 38:105-115, 1978
26. Kibitel J, Hejmadi V, Alas L, O'Connor A, Sutherland BM, Yarosh D: UV-DNA damage in mouse and human cells induces the expression of tumor necrosis factor alpha. Photochem Photobiol 67:541-546, 1998
27. Kim T-Y, Kripke ML, Ullrich SE: Immunosuppression by factors released from UV-irradiated epidermal cells: selective effects on the generation of contact and delayed hypersensitivity after exposure to UVA or UVB radiation. J Invest Dermatol 94:26-32, 1990
28. Klefstrom J, Arighi E, Littlewood T, Jaattela M, Saksela E, Evan GI, Alitalo K: Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NF-kappaB activation. EMBO 16:7382-7392, 1997
29. Kock A, Schwarz T, Kirnbauer R, Urbanski A, Perry P, Ansel JC, Luger TA: Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 172:1609-1614, 1990
30. Kripke ML, Cox PA, Alas LG, Yarosh DB: Pyrimidine dimers in DNA initiate systemic immunosuppression in UV-irradiated mice. Proc Natl Acad Sci 89:7516-7520, 1992
31. Leverkus M, Yaar M, Gilchrest BA: Fas/Fas ligand interaction contributes to UV-induced apoptosis in human keratinocytes. Exp Cell Res 232:255-262, 1997
32. Leverkus M, Yaar M, Eller MS, Tang EH, Gilchrest BA: Post-transcriptional regulation of UV induced TNF-alpha expression. J Invest Dermatol 110:353-357, 1998
33. Lisby S, Muller KM, Jongencel CV, Saurat JH, HauSeries C: Nickel and skin irritants up-regulate tumor necrosis factor-alpha mRNA in keratinocytes by different but potentially synergistic mechanisms. Intl Immunol 7:343-352, 1985
34. Lu X, Lane DP: Differential induction of trancriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndrome? Cell 75:765-778, 1993
35. Lu X, Burbidge SA, Griffin S, Smith KM: Discordance between accumulated p53 protein level and its transcriptional activity in response to u.v. radiation. Oncogene 13:413-418, 1996
36. Mack DH, Vartikar J, Pipas JM, Laimins LA: Specific repression of TATA-mediated but not initiator-mediated transcription by wild type p53. Nature 363:281-283, 1993
37. Maeda T, Eller MS, Hedayati M, Grossman L, Gilchrest BA: Enhanced repair of benzo (a) pyrene-induced DNA damage in human cells treated with thymidine dinucleotides. Mut Res 433:137-145, 1999
38. Miyauchi-Hashimoto H, Tanaka K, Horio T: Enhanced inflammation and immunosuppression by ultraviolet radiation in xeroderma pigmentosum group A (XPA) model mice. J Invest Dermatol 107:343-348, 1996
39. Moss ML, Jin SL, Milla ME, et al: Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385:733-736, 1997
40. Nelson WG, Kastan MB: DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol Cell Biol 14:1815-1823, 1994
41. Noonberg SB, Garovoy MR, Hunt CA: Characteristics of oligonucleotide uptake in human keratinocyte cultures. J Invest Dermatol 101:727-731, 1993
42. Pedeux R, Al-Irani N, Marteau C, Pellicier F, Branche R, Ozturk M, Franchi J, Dore JF: Thymidine dinucleotides induce S phase cell cycle arrest in addition to increased melanogenesis in human melanocytes. J Invest Dermatol 111:472-477, 1998
43. Rheinwald JG, Jermaine E, Beckett MA, Human Carcinogenesis. In: Human Carcinogenesis C.C. Harris, H.N. Autrup (eds). New York: Academic Press, 1983, pp. 85-96
44. Rivas JM, Ullrich SE: The role of IL-4, IL-10, and TNF-alpha in the immune suppression induced by ultraviolet radiation. J Leukoc Biol 56:769-775, 1994
45. Schafer H, Diebel J, Arlt A, Trauzold A, Schmidt WE: The promoter of human p22/PACAP response gene l (PRG1) contains functional binding sites for the p53 tumor suppressor and for NFkappaB. FEBS Lett 436:139-143, 1998
46. Setlow RB, Carrier WL: Pyrimidine dimers in ultraviolet-irradiated DNAs. J Mol Biol 17:237-254, 1966
47. Seto E, Usheva A, Zambetti GP, et al: Wild type p53 binds to the TATA-binding protein and represses transcription. Proc Natl Acad Sci USA 89:12028-12032, 1992
48. Simon JC, Mosmann T, Edelbaum D, Schopf E, Bergstresser PR, Cruz PD Jr: In vivo evidence that ultraviolet B-induced suppression of allergic contact sensitivity is associated with functional inactivation of Th1 cells. Photodermatol Photoimmunol Photomed 10:206-211, 1994
49. Smith ML, Fornace AJ Jr: p53-mediated protective responses to UV irradiation. Proc Natl Acad Sci USA 94:12255-12257, 1997
50. Stern RS, Laird N, Melski J, Parrish JA, Fitzpatrick TB, Bleich HL: Cutaneous squamous-cell carcinoma in patients treated with PUVA. N Engl J Med 310:1156-1161, 1984
51. Stern RS, Nichols KT, Vakeva LH: Malignant melanoma in patients treated fro psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA follow-up study. N Eng J Med 336:1041-1045, 1997
52. Sutherland BM, Harber LC, Kochevar I: Pyrimidine dimer formation and repair in human skin. Cancer Res 40:3181-3185, 1980
53. Toews GB, Bergstresser PR, Streilein JW: Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J Immunol 124:445-453, 1980
54. White PJ, Fogarty RD, Liepe IJ, Delaney PM, Werther GA, Wraight CJ: Live confocal microscopy of oligonucleotide uptake by keratinocytes in human skin grafts on nude mice. J Invest Dermatol 112:887-892, 1999a
55. White PJ, Fogarty RD, McKean SC, Venables DJ, Werther GA, Wraight CJ: Oligonucleotide uptake in cultured keratinocytes: influence of confluence, cationic liposomes, and keratinocyte cell type. J Invest Dermatol 112:699-705, 1999b
56. Wintzen M, Yaar M, Burbach JP, Gilchrest BA: Proopiomelanocortin gene product regulation in keratinocytes. J Invest Dermatol 106:673-678, 1996
57. Yeung MC, Lau AS: Tumor suppressor p53 as a component of the tumor necrosis factor-induced, protein kinase PKR-mediated apoptotic pathway in human promonocytic U937 cells, J Biol Chem 273:25198-25202, 1998
58. Yoshikawa T, Streilein JW: Tumor necrosis factor-alpha and ultraviolet B light have similar effects on contact hypersensitivity in mice, Reg Immunol 3:139-144, 1990